{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:05:31Z","timestamp":1760015131230,"version":"3.40.3"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T00:00:00Z","timestamp":1401321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T00:00:00Z","timestamp":1401321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11739-014-1077-4","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T13:37:02Z","timestamp":1401284222000},"page":"501-511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Identification and management of invasive mycoses in internal medicine: a road-map for physicians"],"prefix":"10.1007","volume":"9","author":[{"given":"Marco","family":"Falcone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercole","family":"Concia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido","family":"Iori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Lo Cascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Pea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"key":"1077_CR1","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/infdis\/167.5.1247","volume":"167","author":"CM Becksague","year":"1993","unstructured":"Becksague CM, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal-infections in the United States, 1980\u20131990. J Infect Dis 167:1247\u20131251","journal-title":"J Infect Dis"},{"key":"1077_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1086\/520192","volume":"29","author":"MB Edmond","year":"1999","unstructured":"Edmond MB, Wallace SE, McClish DK et al (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239\u2013244","journal-title":"Clin Infect Dis"},{"key":"1077_CR3","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/cid\/cis021","volume":"54","author":"DR Andes","year":"2012","unstructured":"Andes DR, Safdar N, Baddley JW et al (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110\u20131122","journal-title":"Clin Infect Dis"},{"issue":"2 Suppl","key":"1077_CR4","first-page":"19","volume":"6","author":"A Mazzone","year":"2012","unstructured":"Mazzone A, Concia E, Falcone M, Pea F, Rossolini G (2012) Invasive fungal infections in the setting of internal medicine: an emergent challenge. Ital J Med 6(2 Suppl):19\u201335","journal-title":"Ital J Med"},{"key":"1077_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2165\/00002512-200017040-00005","volume":"17","author":"K Rockwood","year":"2000","unstructured":"Rockwood K, Hogan DB, MacKnight C (2000) Conceptualisation and measurement of frailty in elderly people. Drugs Aging 17:295\u2013302","journal-title":"Drugs Aging"},{"key":"1077_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12603-010-0045-6","volume":"14","author":"RJ Gobbens","year":"2010","unstructured":"Gobbens RJ, Luijkx KG, Wijnen-Sponselee MT, Schols JM (2010) Towards an integral conceptual model of frailty. J Nutr Health Aging 14:175\u2013181","journal-title":"J Nutr Health Aging"},{"key":"1077_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","volume":"59","author":"LP Fried","year":"2004","unstructured":"Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G (2004) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 59:255\u2013263","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1077_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11739-012-0796-7","volume":"7","author":"M Falcone","year":"2012","unstructured":"Falcone M, Blasi F, Menichetti F, Pea F, Violi F (2012) Pneumonia in older frail patients: an up to date. Intern Emerg Med 7:415\u2013424","journal-title":"Intern Emerg Med"},{"key":"1077_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","volume":"2","author":"G Gavazzi","year":"2002","unstructured":"Gavazzi G, Krause KH (2002) Ageing and infection. Lancet Infect Dis 2:659\u2013666","journal-title":"Lancet Infect Dis"},{"key":"1077_CR10","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1086\/427690","volume":"40","author":"S Rajagopalan","year":"2005","unstructured":"Rajagopalan S (2005) Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis 40:990\u2013996","journal-title":"Clin Infect Dis"},{"key":"1077_CR11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/myc.12090","volume":"56","author":"R Luzzati","year":"2013","unstructured":"Luzzati R, Cavinato S, Giangreco M et al (2013) Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial Candidemia in elderly patients: a matched case\u2013control study. Mycoses 56:664\u2013671","journal-title":"Mycoses"},{"key":"1077_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/13693786.2011.604046","volume":"50","author":"R Caccese","year":"2012","unstructured":"Caccese R, Carfagna P, Pistilli N et al (2012) Candida thrombophlebitis of central veins: case report and review. Med Mycol 50:299\u2013304","journal-title":"Med Mycol"},{"key":"1077_CR13","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1093\/jac\/dkq297","volume":"65","author":"M Falcone","year":"2010","unstructured":"Falcone M, Accarpio F, Venditti M et al (2010) Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis. J Antimicrob Chemother 65:2266\u20132267","journal-title":"J Antimicrob Chemother"},{"key":"1077_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1179\/joc.2010.22.6.397","volume":"22","author":"M Falcone","year":"2010","unstructured":"Falcone M, Russo A, De Rosa FG et al (2010) Clinical experience of anidulafungin for the treatment of patients with documented candidemia. J Chemother 22:397\u2013401","journal-title":"J Chemother"},{"key":"1077_CR15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1086\/382874","volume":"38","author":"I Raad","year":"2004","unstructured":"Raad I, Hanna H, Boktour M et al (2004) Management of central venous catheters in patients with cancer and candidemia with cancer and candidemia. Clin Infect Dis 38:1119\u20131127","journal-title":"Clin Infect Dis"},{"key":"1077_CR16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.idc.2006.09.007","volume":"20","author":"GS Alarc\u00f3n","year":"2006","unstructured":"Alarc\u00f3n GS (2006) Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis\/dermatomyositis. Infect Dis Clin North Am 20:849\u2013875","journal-title":"Infect Dis Clin North Am"},{"key":"1077_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1592\/phco.2005.25.9.1181","volume":"25","author":"DJ Rychly","year":"2005","unstructured":"Rychly DJ, Di Piro JT (2005) Infections associated with tumor necrosis factor-a antagonists. Pharmacotherapy 25:1181\u20131192","journal-title":"Pharmacotherapy"},{"key":"1077_CR18","doi-asserted-by":"crossref","unstructured":"Cei M, Pardelli R, Sani S, Mumoli N (2014) Local resistance patterns to antimicrobials in internal medicine: a focused report from the REGIMEN (REGistro Infezioni in MEdicina INterna) study. Clin Exp Med 14:77\u201382","DOI":"10.1007\/s10238-012-0219-0"},{"key":"1077_CR19","doi-asserted-by":"publisher","first-page":"e24198","DOI":"10.1371\/journal.pone.0024198","volume":"6","author":"M Bassetti","year":"2011","unstructured":"Bassetti M, Taramasso L, Nicco E et al (2011) Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 6:e24198","journal-title":"PLoS One"},{"key":"1077_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/cid\/cit362","volume":"57","author":"M Guastalegname","year":"2013","unstructured":"Guastalegname M, Russo A, Falcone M, Giuliano S, Venditti M (2013) Candidemia subsequent to severe infection due to Clostridium difficile: is there a link? Clin Infect Dis 57:772\u2013774","journal-title":"Clin Infect Dis"},{"key":"1077_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0161-6420(94)31175-4","volume":"101","author":"SP Donahue","year":"1994","unstructured":"Donahue SP, Greven CM et al (1994) Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 101:1302\u20131309","journal-title":"Ophthalmology"},{"issue":"Suppl. 7","key":"1077_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/1469-0691.12038","volume":"18","author":"M Cuenca-Estrella","year":"2012","unstructured":"Cuenca-Estrella M, Verweij PE et al (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18(Suppl. 7):9\u201318","journal-title":"Clin Microbiol Infect"},{"key":"1077_CR23","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1128\/JCM.41.10.4714-4717.2003","volume":"41","author":"LL Horvath","year":"2003","unstructured":"Horvath LL, Hospenthal DR, Murray CK, Dooley DP (2003) Detection of simulated candidemia by the BACTEC 9240 system with plus aerobic\/F and anaerobic\/F blood culture bottles. J Clin Microbiol 41:4714\u20134717","journal-title":"J Clin Microbiol"},{"key":"1077_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1099\/jmm.0.038166-0","volume":"61","author":"CC Lai","year":"2012","unstructured":"Lai CC, Wang CY, Liu WL, Huang YT, Hsueh PR (2012) Time to blood culture positivity of different Candida species causing fungemia. J Med Microbiol 61:701\u2013704","journal-title":"J Med Microbiol"},{"key":"1077_CR25","doi-asserted-by":"publisher","first-page":"R249","DOI":"10.1186\/cc10507","volume":"15","author":"B Posteraro","year":"2011","unstructured":"Posteraro B, De Pascale M, Tumbarello M et al (2011) Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1\u00ae3)-b-d-glucan assay, Candida score, and colonization index. Crit Care 15:R249","journal-title":"Crit Care"},{"key":"1077_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1086\/421944","volume":"39","author":"Z Odabasi","year":"2004","unstructured":"Odabasi Z, Mattiuzzi G, Estey E et al (2004) \u03b2-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39:199\u2013205","journal-title":"Clin Infect Dis"},{"key":"1077_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1128\/JCM.05267-11","volume":"50","author":"A Onishi","year":"2012","unstructured":"Onishi A, Sugiyama D, Kogata Y, Saegusa J et al (2012) Diagnostic accuracy of serum 1,3-\u03b2-d-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 50:7\u201315","journal-title":"J Clin Microbiol"},{"issue":"1A","key":"1077_CR28","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.amjmed.2011.10.008","volume":"125","author":"L Ostrosky-Zeichner","year":"2012","unstructured":"Ostrosky-Zeichner L (2012) Invasive mycoses: diagnostic challenges. Am J Med 125(1A):S14\u2013S24","journal-title":"Am J Med"},{"key":"1077_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/1040841X.2011.581223","volume":"37","author":"JL Hsu","year":"2011","unstructured":"Hsu JL, Ruoss SJ, Bower ND et al (2011) Diagnosing invasive fungal disease in critically ill patients. Crit Rev Microbiol 37:277\u2013312","journal-title":"Crit Rev Microbiol"},{"key":"1077_CR30","doi-asserted-by":"crossref","unstructured":"Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C (2010) The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 14: R222","DOI":"10.1186\/cc9365"},{"key":"1077_CR31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1469-0691.2009.02931.x","volume":"16","author":"MC Arendrup","year":"2010","unstructured":"Arendrup MC, Bergmann OJ, Larsson L et al (2010) Detection of candidaemia in patients with and without underlying haematological disease. Clin Microbiol Infect 16:855\u2013862","journal-title":"Clin Microbiol Infect"},{"key":"1077_CR32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1099\/0022-1317-51-5-433","volume":"51","author":"B Sendid","year":"2002","unstructured":"Sendid B, Poirot JL, Tabouret M et al (2002) Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 51:433\u2013442","journal-title":"J Med Microbiol"},{"key":"1077_CR33","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1128\/JCM.01461-12","volume":"50","author":"A Aittakorpi","year":"2012","unstructured":"Aittakorpi A, Kuusela P, Koukila-K\u00e4hk\u00f6l\u00e4 P et al (2012) Accurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based prove-it sepsis assay. J Clin Microbiol 50:3635\u20133640","journal-title":"J Clin Microbiol"},{"issue":"Suppl. 7","key":"1077_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T et al (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl. 7):19\u201337","journal-title":"Clin Microbiol Infect"},{"key":"1077_CR35","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1186\/cc10514","volume":"15","author":"DH Kett","year":"2011","unstructured":"Kett DH, Shorr AF, Reboli AC et al (2011) Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis. Crit Care 15:R253","journal-title":"Crit Care"},{"key":"1077_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1471-2334-11-261","volume":"11","author":"AC Reboli","year":"2011","unstructured":"Reboli AC, Shorr AF, Rotstein C et al (2011) Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome. BMC Infect Dis 11:261","journal-title":"BMC Infect Dis"},{"key":"1077_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1086\/505204","volume":"43","author":"JA Vazquez","year":"2006","unstructured":"Vazquez JA, Sobel JD (2006) Anidulafungin: a novel echinocandin. Clin Infect Dis 43:215\u2013222","journal-title":"Clin Infect Dis"},{"key":"1077_CR38","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1086\/501020","volume":"42","author":"PH Chandrasekar","year":"2006","unstructured":"Chandrasekar PH, Sobel JD (2006) Micafungin: a new echinocandin. Clin Infect Dis 42:1171\u20131178","journal-title":"Clin Infect Dis"},{"key":"1077_CR39","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1086\/375080","volume":"36","author":"SC Deresinski","year":"2003","unstructured":"Deresinski SC, Stevens DA (2003) Caspofungin. Clin Infect Dis 36:1445\u20131457","journal-title":"Clin Infect Dis"},{"key":"1077_CR40","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1128\/AAC.01490-12","volume":"57","author":"RG Hall","year":"2013","unstructured":"Hall RG, Swancutt MA, Meek C, Leff R, Gumbo T (2013) Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths. Antimicrob Agents Chemother 57:2259\u20132264","journal-title":"Antimicrob Agents Chemother"},{"key":"1077_CR41","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1128\/AAC.05193-11","volume":"55","author":"RG Hall","year":"2011","unstructured":"Hall RG, Swancutt MA, Gumbo T (2011) Fractal geometry and the pharmacometrics of micafungin in overweight, obese, and extremely obese people. Antimicrob Agents Chemother 55:5107\u20135112","journal-title":"Antimicrob Agents Chemother"},{"key":"1077_CR42","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1056\/NEJMct060052","volume":"355","author":"JE Bennett","year":"2006","unstructured":"Bennett JE (2006) Echinocandins for candidemia in adults without neutropenia. N Engl J Med 355:1154\u20131159","journal-title":"N Engl J Med"},{"key":"1077_CR43","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1517\/13543784.12.8.1313","volume":"12","author":"NP Wiederhold","year":"2003","unstructured":"Wiederhold NP, Lewis RE (2003) The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy. Expert Opin Investig Drugs 12:1313\u20131333","journal-title":"Expert Opin Investig Drugs"},{"key":"1077_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/MD.0b013e3181a693f8","volume":"88","author":"M Falcone","year":"2009","unstructured":"Falcone M, Barzaghi N, Carosi G et al (2009) Italian study on endocarditis. Candida infective endocarditis: report of 15 cases from a prospective multicenter study. Medicine (Baltimore) 88:160\u2013168","journal-title":"Medicine (Baltimore)"},{"key":"1077_CR45","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1128\/JCM.00308-13","volume":"51","author":"MA Pfaller","year":"2013","unstructured":"Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M (2013) Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. J Clin Microbiol 51:2571\u20132581","journal-title":"J Clin Microbiol"},{"key":"1077_CR46","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1164\/rccm.200505-727SO","volume":"173","author":"BH Segal","year":"2006","unstructured":"Segal BH, Walsh TJ (2006) Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 173:707\u2013717","journal-title":"Am J Respir Crit Care Med"},{"key":"1077_CR47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","volume":"170","author":"SJ Vandecasteele","year":"2004","unstructured":"Vandecasteele SJ, Meersseman W, Wilmer A et al (2004) Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 170:621\u2013625","journal-title":"Am J Respir Crit Care Med"},{"key":"1077_CR48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1469-0691.2005.01143.x","volume":"11","author":"F Ader","year":"2005","unstructured":"Ader F, Nseir S, Le Berre R et al (2005) Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 11:427\u2013429","journal-title":"Clin Microbiol Infect"},{"key":"1077_CR49","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/13693786.2010.535030","volume":"49","author":"M Falcone","year":"2011","unstructured":"Falcone M, Massetti AP, Russo A, Vullo V, Venditti M (2011) Invasive aspergillosis in patients with liver disease. Med Mycol 49:406\u2013413","journal-title":"Med Mycol"},{"key":"1077_CR50","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.ijid.2011.04.005","volume":"15","author":"M Falcone","year":"2011","unstructured":"Falcone M, Shindo Y, Venditti M, Kollef MH (2011) Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia. Int J Infect Dis 15:e545\u2013e550","journal-title":"Int J Infect Dis"},{"key":"1077_CR51","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1183\/09031936.00062206","volume":"30","author":"P Bulpa","year":"2007","unstructured":"Bulpa P, Dive A, Sibille Y (2007) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 30:782\u2013800","journal-title":"Eur Respir J"},{"key":"1077_CR52","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 46:1813\u20131821","journal-title":"Clin Infect Dis"},{"key":"1077_CR53","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/j.1469-0691.2003.00792.x","volume":"9","author":"M Cornet","year":"2003","unstructured":"Cornet M, Mallat H, Somme D et al (2003) Fulminant invasive pulmonary aspergillosis in immunocompetent patients\u2014a two-case report. Clin Microbiol Infect 9:1224\u20131227","journal-title":"Clin Microbiol Infect"},{"key":"1077_CR54","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1164\/rccm.2407004","volume":"170","author":"DW Denning","year":"2004","unstructured":"Denning DW (2004) Aspergillosis in \u201cnonimmunocompromised\u201d critically ill patients. Am J Respir Crit Care Med 170:580\u2013581","journal-title":"Am J Respir Crit Care Med"},{"key":"1077_CR55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s001340050334","volume":"23","author":"MG Petri","year":"1997","unstructured":"Petri MG, Konig J, Moecke HP et al (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intens Care Med 23:317\u2013325","journal-title":"Intens Care Med"},{"key":"1077_CR56","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1086\/341971","volume":"35","author":"E Peter","year":"2002","unstructured":"Peter E, Bakri F, Ball DM, Cheney RT, Segal BH (2002) Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy. Clin Infect Dis 35:e54\u2013e56","journal-title":"Clin Infect Dis"},{"key":"1077_CR57","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1128\/IAI.73.1.494-503.2005","volume":"73","author":"V Balloy","year":"2005","unstructured":"Balloy V, Huerre M, Latge JP, Chignard M (2005) Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 73:494\u2013503","journal-title":"Infect Immun"},{"key":"1077_CR58","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1086\/517672","volume":"26","author":"J Rello","year":"1998","unstructured":"Rello J, Esandi ME, Mariscal D et al (1998) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 26:1473\u20131475","journal-title":"Clin Infect Dis"},{"key":"1077_CR59","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1439-0507.2010.01998.x","volume":"54","author":"P Carfagna","year":"2011","unstructured":"Carfagna P, Brandimarte F, Caccese R et al (2011) Fatal invasive pulmonary aspergillosis complicating influenza A (H1N1)v infection. Mycoses 54:549\u2013551","journal-title":"Mycoses"},{"key":"1077_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"Meersseman W, Lagrou K, Maertens J et al (2008) Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177:27\u201334","journal-title":"Am J Respir Crit Care Med"},{"key":"1077_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00428-006-0364-5","volume":"450","author":"C Maris","year":"2007","unstructured":"Maris C, Martin B, Creteur J et al (2007) Comparison of clinical and post-mortem findings in intensive care unit patients. Virchows Arch 450:329\u2013333","journal-title":"Virchows Arch"},{"key":"1077_CR62","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1179\/joc.2011.23.5.290","volume":"23","author":"A Russo","year":"2011","unstructured":"Russo A, Falcone M, Vena A et al (2011) Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience. J Chemother 23:290\u2013294","journal-title":"J Chemother"},{"key":"1077_CR63","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1086\/505870","volume":"43","author":"A Cornillet","year":"2006","unstructured":"Cornillet A, Camus C, Nimubona S et al (2006) Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and non-neutropenic patients: a 6-year survey. Clin Infect Dis 43:577\u2013584","journal-title":"Clin Infect Dis"},{"key":"1077_CR64","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1086\/657065","volume":"51","author":"M Nucci","year":"2010","unstructured":"Nucci M, Nou\u00e9r SA, Grazziutti M et al (2010) Probable invasive probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. Clin Infect Dis 51:1273\u20131280","journal-title":"Clin Infect Dis"},{"key":"1077_CR65","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","volume":"16","author":"J Guinea","year":"2010","unstructured":"Guinea J, Torres-Narbona M, Gij\u00f2n P et al (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16:870\u2013877","journal-title":"Clin Microbiol Infect"},{"key":"1077_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/518852","volume":"45","author":"W Meersseman","year":"2007","unstructured":"Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E (2007) Invasive aspergillosis in the intensive care unit. Clin Infect Dis 45:205\u2013216","journal-title":"Clin Infect Dis"},{"key":"1077_CR67","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1128\/JCM.42.1.435-438.2004","volume":"42","author":"EJ Kwak","year":"2004","unstructured":"Kwak EJ, Husain S, Obman A et al (2004) Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 42:435\u2013438","journal-title":"J Clin Microbiol"},{"key":"1077_CR68","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12185-009-0429-8","volume":"90","author":"SI Kimura","year":"2009","unstructured":"Kimura SI, Odawara J, Aoki T et al (2009) Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients. Int J Hematol 90:463\u2013470","journal-title":"Int J Hematol"},{"key":"1077_CR69","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1469-0691.2010.03357.x","volume":"17","author":"J Acosta","year":"2011","unstructured":"Acosta J, Catalan M, del Palacio-Per\u00e9z-Medel A et al (2011) A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1\u00a0\u2192\u00a03)-\u03b2-d-glucan chromogenic assay in serum samples. Clin Microbiol Infect 17:1053\u20131060","journal-title":"Clin Microbiol Infect"},{"key":"1077_CR70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327\u2013360","journal-title":"Clin Infect Dis"},{"key":"1077_CR71","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1128\/AAC.01042-09","volume":"53","author":"JL Crandon","year":"2009","unstructured":"Crandon JL, Banevicius MA, Fang AF et al (2009) Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults. Antimicrob Agents Chemother 53:5102\u20135107","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-014-1077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-014-1077-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-014-1077-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-014-1077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:00:38Z","timestamp":1744149638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-014-1077-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1007\/s11739-014-1077-4","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"type":"print","value":"1828-0447"},{"type":"electronic","value":"1970-9366"}],"subject":[],"published":{"date-parts":[[2014,5,29]]},"assertion":[{"value":"4 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}